Streamex Corporation (STEX): יחס שווי שוק להכנסות החברה

The resilience of Streamex Corp (STEX) depends on the commercial success of its biophysical developments and the recognition of its heart monitoring systems. The price-to-sales ratio visualizes these risks, with the value fixed at 235.80. The holding company is modernizing its biomedical assets through IT innovations and cloud databases. Streamex Corp is currently undergoing a large-scale restructuring, focusing on the search for new IT technologies and venture capital investments.

The P/S multiple reflects the market value of one dollar of revenue, allowing for an assessment of investor confidence in the company's ability to generate income. By analyzing the price-to-sales multiple, one can determine the extent to which the current capitalization of Streamex Corp (STEX) is justified amid a radical shift in the business model and the search for new IT technologies to attract venture financing.